InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
41
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Kelly William John, Chief Financial Officer. Director active across 1 company, notably Vicarious Surgical Inc.. Aggregated, 48 reports have been published. Split: 0 buy · 41 sells. Total volume traded: €265k. Activity tracked since 20 December 2021. The latest transaction was disclosed on 23 December 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kelly William John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
19 shares@ US$12.20210.1% of flowClass A Common StockSEC:0001213900-24-112330:0
218 shares@ US$13.40940.9% of flowClass A Common StockSEC:0001213900-24-105583:0
109 shares@ US$8.95630.3% of flowClass A Common StockSEC:0001213900-24-100909:0
37 shares@ US$5.7470.1% of flowClass A Common StockSEC:0001213900-24-081025:0
1,083 shares0Class A Common StockSEC:0001213900-24-076173:0
2,812 shares0Class A Common StockSEC:0001213900-24-071364:0
27 shares@ US$7.96630.1% of flowClass A Common StockSEC:0001013762-24-000388:0
6,528 shares@ US$0.32130.6% of flowClass A Common StockSEC:0001213900-24-049598:0
6,546 shares@ US$0.3880.8% of flowClass A Common StockSEC:0001213900-24-045509:0
1,290 shares@ US$0.3390.1% of flowClass A Common StockSEC:0001213900-24-024749:0
7,535 shares@ US$0.37080.9% of flowClass A Common StockSEC:0001213900-24-020148:0
7,555 shares@ US$0.36440.8% of flowClass A Common StockSEC:0001213900-24-015860:0
4,984 shares@ US$0.44520.7% of flowClass A Common StockSEC:0001213900-23-084709:0
4,858 shares@ US$0.48730.7% of flowClass A Common StockSEC:0001013762-23-002456:0
1,107 shares@ US$0.78770.3% of flowClass A Common StockSEC:0001213900-23-078780:0
6,461 shares@ US$0.96281.9% of flowClass A Common StockSEC:0001213900-23-075087:0
6,478 shares@ US$0.92591.8% of flowClass A Common StockSEC:0001213900-23-069798:0
4,985 shares@ US$0.86141.3% of flowClass A Common StockSEC:0001213900-23-064919:0
4,859 shares@ US$1.8272.7% of flowClass A Common StockSEC:0001213900-23-055122:0
1,106 shares@ US$2.040.7% of flowClass A Common StockSEC:0001213900-23-051008:0
304,049 shares0Class A Common StockSEC:0001213900-23-046722:0
6,479 shares@ US$2.25534.5% of flowClass A Common StockSEC:0001213900-23-042680:0
5,039 shares@ US$2.16093.3% of flowClass A Common StockSEC:0001213900-23-037359:0
4,911 shares@ US$2.15173.2% of flowClass A Common StockSEC:0001213900-23-028189:0
1,139 shares@ US$2.3880.8% of flowClass A Common StockSEC:0001213900-23-022510:0
25 of 48 declarations
About Kelly William John
Kelly William John is Chief Financial Officer at Vicarious Surgical Inc. on XNAS. He has filed 48 disclosures in total, and across the sampled recent filings from 2021-11-26 to 2024-12-26, the reported transactions are exclusively sales, for an amount of EUR 265222.
